Riley Joseph Deutsch

Mr. Riley Joseph Deutsch

Duke University, Durham, California, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in BME Frontiers
Verified
Journal Article
Open access
RWRoujia Wang
Roujia Wang
RDRiley Joseph Deutsch
Riley Joseph Deutsch
ESEnakshi D. Sunassee
Enakshi D. Sunassee
BCBrian T. Crouch
Brian T. Crouch
NRNirmala Ramanujam
Nirmala Ramanujam
Objective and Impact Statement: We developed a generalized computational approach to design uniform, high-intensity excitation light for low-cost, quantitative fluorescence imaging of in vitro, ex vivo, and in vivo samples with a single device. Introduction: Fluorescence imaging is a ubiquitous tool for biomedical applications. Researchers extensively modify existing systems for tissue imaging, increasing the time and effort needed for translational research and thick tissue imaging. These modifications are application-specific, requiring new designs to scale across sample types. Methods: We implemented a computational model to simulate light propagation from multiple sources. Using a global optimization algorithm and a custom cost function, we determined the spatial positioning of optical fibers to generate 2 illumination profiles. These results were implemented to image core needle biopsies, preclinical mammary tumors, or tumor-derived organoids. Samples were stained with molecular probes and imaged with uniform and nonuniform illumination. Results: Simulation results were faithfully translated to benchtop systems. We demonstrated that uniform illumination increased the reliability of intraimage analysis compared to nonuniform illumination and was concordant with traditional histological findings. The computational approach was used to optimize the illumination geometry for the purposes of imaging 3 different fluorophores through a mammary window chamber model. Illumination specifically designed for intravital tumor imaging generated higher image contrast compared to the case in which illumination originally optimized for biopsy images was used. Conclusion: We demonstrate the significance of using a computationally designed illumination for in vitro, ex vivo, and in vivo fluorescence imaging. Application-specific illumination increased the reliability of intraimage analysis and enhanced the local contrast of biological features. This approach is generalizable across light sources, biological applications, and detectors.

5 April 2024 in Science Advances
Verified
Journal Article
Open access
ESEnakshi D. Sunassee
Enakshi D. Sunassee
RDRiley Joseph Deutsch
Riley Joseph Deutsch
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
PCPol Castellano-Escuder
Pol Castellano-Escuder
ESElizabeth A. Siebeneck
Elizabeth A. Siebeneck
NRNirmala Ramanujam
Nirmala Ramanujam
Fewer than 20% of triple-negative breast cancer patients experience long-term responses to mainstay chemotherapy. Resistant tumor subpopulations use alternative metabolic pathways to escape therapy, survive, and eventually recur. Here, we show in vivo, longitudinal metabolic reprogramming in residual disease and recurrence of triple-negative breast cancer xenografts with varying sensitivities to the chemotherapeutic drug paclitaxel. Optical imaging coupled with metabolomics reported an increase in non–glucose–driven mitochondrial metabolism and an increase in intratumoral metabolic heterogeneity during regression and residual disease in resistant MDA-MB-231 tumors. Conversely, sensitive HCC-1806 tumors were primarily reliant on glucose uptake and minimal changes in metabolism or heterogeneity were observed over the tumors’ therapeutic life cycles. Further, day-matched resistant HCC-1806 tumors revealed a higher reliance on mitochondrial metabolism and elevated metabolic heterogeneity compared to sensitive HCC-1806 tumors. Together, metabolic flexibility, increased reliance on mitochondrial metabolism, and increased metabolic heterogeneity are defining characteristics of persistent residual disease, features that will inform the appropriate type and timing of therapies.

21 November 2025 in Science Advances
Verified
Journal Article
Open access
RDRiley Joseph Deutsch
Riley Joseph Deutsch
YXYuxuan Xie
Yuxuan Xie
ZRZachary Rabinowitz
Zachary Rabinowitz
MGMarie Goemans
Marie Goemans
PWPratyaksha Wirapati
Pratyaksha Wirapati
RWRalph Weissleder
Ralph Weissleder
Surgical tumor resection is often the only curative option for the nearly 20 million newly diagnosed patients with cancer every year. Fluorescence-guided surgery techniques are being developed in an effort to improve margin detection and surgical resection outcomes, with several systemically administered imaging agents having gained clinical approval. However, it has been challenging to overcome limited margin contrast with current approaches and to navigate procedural complexities of intravenous contrast delivery. We hypothesized that “spray-on probes” with specificity for fibroblast activation protein alpha in peritumoral fibroblasts could improve fluorescence-guided surgery, detect smaller tumors, improve imaging accuracy, and reduce the amount of times a patient is hospitalized. We show that this strategy increases achievable tumor margin contrast by 5- to 10-fold and detects even microscopic cancer deposits. These improvements have the potential to transform patient outcomes by enabling more accurate cancer surgeries, reducing the number of follow-up surgeries, and leading to personalized treatment plans.

19 April 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
RDRiley Joseph Deutsch
Riley Joseph Deutsch
Victoria W D’AgostinoVictoria W D’Agostino
Victoria W D’Agostino
ESEnakshi D. Sunassee
Enakshi D. Sunassee
MKMichelle Kwan
Michelle Kwan
MMMegan Madonna
Megan Madonna
NRNimmi Ramanujam
Nimmi Ramanujam
Aggressive breast cancer has been shown to shift its metabolism towards increased lipid catabolism as the primary carbon source for oxidative phosphorylation. In this study, we present a technique to longitudinally monitor lipid metabolism and oxidative phosphorylation in pre-clinical tumor models to investigate the metabolic changes with mammary tissue development and characterize metabolic differences between primary murine breast cancer and normal mammary tissue. We used optical spectroscopy to measure the signal of two simultaneously injected exogenous fluorescent metabolic reporters: TMRE (oxidative phosphorylation surrogate) and Bodipy FL C16 (lipid catabolism surrogate). We leverage an inverse Monte Carlo algorithm to correct for aberrations resulting from tissue optical properties and to extract vascular endpoints relevant to oxidative metabolism, specifically oxygen saturation (SO2) and hemoglobin concentration ([Hb]). We extensively validated our optical method to demonstrate that our two fluorescent metabolic endpoints can be measured without chemical or optical crosstalk and that dual measurements of both fluorophores in vivo faithfully recapitulate the measurements of each fluorophore independently. We then applied our method to track the metabolism of growing 4T1 and 67NR breast tumors and aging mammary tissue, all highly metabolic tissue types. Our results show the changes in metabolism as a function of mammary age and tumor growth, and these changes can be best distinguished through the combination of endpoints measured with our system. Clustering analysis incorporating both Bodipy FL C16 and TMRE endpoints combined with either SO2 or [Hb] proved to be the most effective in minimizing intra-group variance and maximizing inter-group differences. Our platform can be extended to applications in which long-term metabolic flexibility is important to study, for example in tumor regression, recurrence following dormancy, and responses to cancer treatment.

24 March 2026 in Advanced Science
Verified
Journal Article
Open access
ZRZachary Rabinowitz
Zachary Rabinowitz
RDRiley Joseph Deutsch
Riley Joseph Deutsch
RWRalph Weissleder
Ralph Weissleder
Fluorescence‐guided surgery is an emerging clinical field that aims to improve cancer detection in real‐time, enabling spot‐on therapeutic decisions. The use of fluorescent affinity probes has primarily involved systemically injected probes and, more recently, “spray‐on probes”. A current challenge has been to develop “turn‐off” probes that can be inactivated by a UV light pulse and reduce background noise during iterative decision‐making. Here, we report on the first development of a FAP‐targeted erasable spray‐on probe (ESOP). The probe consists of three components: (i) a highly bright, yellow light‐emitting rhodamine dye, (ii) a photo‐responsive linear triazene linker, and (iii) a FAP affinity ligand. We demonstrate that this probe could enable highly sensitive tumor‐specific margin visualization within minutes after a spray‐on application. Moreover, we show that the fluorescent signals could be fully erased with a 2‐min UV‐light pulse in tissue, permitting iterative staining applications with consistently high tumor‐to‐background ratios (TBRs). ESOP targeted against cancer or host tissue is feasible and is likely to yield transformative impacts on next‐generation cancer surgeries, ultimately improving patient care.

5 October 2026 in Angewandte Chemie
Verified
Journal Article
Open access
PDF file
MSMarkus Staudt
Markus Staudt
CPChristian Poulie
Christian Poulie
ALAndreas Löffler
Andreas Löffler
PMPeter R. Meinig
Peter R. Meinig
RDRiley Joseph Deutsch
Riley Joseph Deutsch
MHMatthias M. Herth
Matthias M. Herth
ZUSAMMENFASSUNG: Click‐Chemie hat sich von seinen Ursprüngen—der Bildung von kovalenten Verbindungen—dahingehend weiterentwickelt, dass es nun auch möglich ist, Bindungen zu brechen, Linker zu spalten und molekulare Fracht freizusetzen, was vielseitige Anwendungen in der chemischen Biologie und Biomedizin ermöglicht hat. Die diesen Verfahren zugrundeliegenden Reaktionssequenzen sind komplex und führen häufig zu Zwischenprodukten, die in einer Sackgasse enden und somit die Effizienz der Spaltung verringern. In dieser Arbeit nutzen wir diese Komplexität gezielt, um einen weiteren Aspekt der Click‐Spaltung von Tetrazinen(Tz) und trans ‐Cyclooctenen(TCO) zu untersuchen. Durch den Austausch der Carbamat‐Funktionalität etablierter Spaltungs‐Tetrazine gegen eine Anilinium‐Abgangsgruppe wird die Tautomerisierung nach der Click‐Reaktion beschleunigt und zeitlich synchronisiert. Dabei entsteht ein Zwischenprodukt, welches Thiole schnell und mit hoher Ausbeute abfangen kann. Die zusätzliche Einführung eines orthogonalen Azids in das Tetrazingerüst ermöglicht eine Mehrkomponentenreaktion im Ein‐Topf‐Verfahren, die eine einfache kombinatorische Synthese hochfunktionalisierter Strukturen erlaubt. Unter Ausnutzung sowohl der Click‐ als auch der Spaltungsreaktion wandelt der Prozess ein Tz/TCO‐Paar auf Abruf in ein ternäres Gerüst um, in das sich Fluorophore, Chelatoren, aktivierbare Wirkstoffe, Proteine, Oligonukleotide und niedermolekulare Zielvektoren integrieren lassen. Dieser modulare Kaskadenaufbau bietet eine effiziente und vielseitige Plattform für die Funktionalisierung von Biomolekülen und niedermolekularen Zielvektoren und eröffnet unmittelbare Anwendungsmöglichkeiten in der Bildgebung, der Theranostik sowie beim Design multivalenter Biokonjugate.